All In MedTech

Device Trial Radar · NCT05852470

Evaluation of Clareon Vivity/Vivity Toric

PMCF (Post Market Clinical Follow-up) Evaluation of Clareon Vivity/Vivity Toric

Last checked: Nov 20, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

155

Actual

Start

May 23, 2023

Primary completion

Oct 27, 2023

Study completion Oct 27, 2023

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
May 10, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Vivity Toric Intraocular Lenses (IOLs) or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits statements with model-specific data.

Conditions

  • Aphakia

Interventions

  • Clareon Vivity/Vivity Toric Extended Vision IOLDevice

    Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.

  • Clareon Monofocal/Clareon Toric IOLDevice

    Single vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Binocular Photopic Best Corrected Distance Visual Acuity (BCDVA) at 3 to 6 Months (90 to 180 Days) Postoperatively After Second Eye ImplantTime frame: Visit 1 (Day 1-14 post Screening Visit, coinciding with Day 90-180 post second eye implantation)
  2. Mean Binocular Photopic Distance Corrected Intermediate Visual Acuity (DCIVA) at 3 to 6 Months (90 to 180 Days) Postoperatively After Second Eye ImplantTime frame: Visit 1 (Day 1-14 post Screening Visit, coinciding with Day 90-180 post second eye implantation)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Wolstan Goldberg Eye Associates

    Torrance, California

  • Eye Center of Northern Colorado, PC

    Fort Collins, Colorado

  • Grosinger, Spigelman & Grey Eye Surgeons, P.C.

    Bloomfield Hills, Michigan

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.